PRELID1

Chr 5

PRELI domain containing 1

Also known as: CGI-106, PRELI, PX19, SBBI12

The encoded protein functions as a phosphatidic acid transporter in mitochondria that regulates cardiolipin accumulation and modulates the mitochondrial apoptotic pathway. Mutations cause autosomal recessive neurodegeneration with brain atrophy, characterized by early-onset developmental delay, seizures, and progressive neurological decline. The gene shows moderate constraint against loss-of-function variants, and the condition primarily affects the central nervous system with onset typically in infancy or early childhood.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
5
Pubs (1 yr)
61
P/LP submissions
0%
P/LP missense
0.67
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryPRELID1
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.29) despite low pLI — interpret in context.
📋
ClinVar Variants
59 unique Pathogenic / Likely Pathogenic· 28 VUS of 99 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.67LOEUF
pLI 0.115
Z-score 2.44
OE 0.29 (0.140.67)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.26Z-score
OE missense 0.69 (0.580.82)
88 obs / 128.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.29 (0.140.67)
00.351.4
Missense OE0.69 (0.580.82)
00.61.4
Synonymous OE0.80
01.21.6
LoF obs/exp: 4 / 13.8Missense obs/exp: 88 / 128.2Syn Z: 1.10
DN
0.7326th %ile
GOF
0.78top 25%
LOF
0.3454th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

99 submitted variants in ClinVar

Classification Summary

Pathogenic53
Likely Pathogenic6
VUS28
Likely Benign2
53
Pathogenic
6
Likely Pathogenic
28
VUS
2
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
53
0
53
Likely Pathogenic
0
0
6
0
6
VUS
0
20
8
0
28
Likely Benign
0
1
1
0
2
Benign
0
0
0
0
0
Total02168089

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PRELID1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 3 results · since 2015Search PubMed ↗